Agfa HealthCare Signs IMPAX RIS/PACS Agreement with University Medical Center in Maastricht

Agfa HealthCareAgfa HealthCare has signed an agreement with the Maastricht Universitair Medisch Centrum+ (University Medical Center - UMC+) in The Netherlands to install its IMPAX Radiology Information System/Picture Archiving and Communication System (RIS/PACS) and IMPAX for Nuclear Medicine. The solutions will provide workflow support to both the radiology and nuclear medicine departments. The contract was signed on 18 October 2011, and implementation will begin in January 2012.

Supporting the entire patient clinical path
Maastricht UMC+ was created in January 2008 by the merging of the university hospital of Maastricht (azM) and the Faculty of Health, Medicine and Life Sciences of the Maastricht University. In addition to healthcare, UMC+ focuses on education and research activities. It counts over 700 beds, employs over 5000 hospital staff members and educates over 4000 university students. Maastricht UMC+ (the + refers to the integration of medicine and health science in the care chain) treats patients with all types of diseases, from the simple to the very complex.

The agreement between UMC+ and Agfa HealthCare includes the IMPAX RIS/PACS and IMPAX for Nuclear Medicine. These solutions enable users to electronically manage radiology and nuclear medicine operations, end-to-end, from exam ordering to patient registration, through worklist generation and medical reporting, to report distribution. The specialized solutions for radiology and nuclear medicine departments are designed to boost efficiency, improve workflow, increase productivity and help deliver high-quality information to hospital staff, patients and referring physicians.

Solution handles all nuclear medicine exams
The IMPAX for Nuclear Medicine information system comprises an intelligent planning module, which supports complex workflows, and can handle comprehensive resource planning and scheduling across multiple departments. The solution also includes the fully integrated, vendor-neutral Oasis for IMPAX, developed in cooperation with Segami Corp., which makes it possible to work with, analyze and report all nuclear medicine exams, including SPECT and PET, and multi-modality exams, from a single workstation.

The IMPAX solutions offer the extensive functionality, workflow support and system reliability Maastricht UMC+ requires, as well as improved efficiency for the in-vivo diagnostic process and a next-generation roadmap. As Maastricht UMC+ produces more than 199,000 medical images each year; the IMPAX solutions will enable improvements to the efficiency of the medical imaging.

Agfa HealthCare was the only supplier that could meet the specific requirements of UMC+. With its installed base in Europe and around the world, the company is a market leader in RIS/PACS and Regional Health.

Related news articles:

About Agfa
The Agfa-Gevaert Group is one of the world's leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,948 million euro in 2010.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2010 were 1,180 million euro.

Most Popular Now

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...